Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03785860 · ClinicalTrials.gov registry record · NA

The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects

A NA study of Gut -Microbiota, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03785860 is a NA study of Gut -Microbiota that has completed, run by University of California, Davis. The registered enrollment target is 20 participants, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03785860, a NA study of Gut -Microbiota, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, overall gut health, and markers of inflammation.

Conditions Studied

Interventions

  • OTHER Placebo
  • OTHER Dietary Fiber

Study Locations (1)

California

  • University of California, Davis Department of Nutrition - Davis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-05-13
Est. Completion 2019-12-23
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03785860

The ClinicalTrials.gov registry entry for NCT03785860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 48-participant average among 9 other Gut -Microbiota trials with a reported enrollment target (58% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gut -Microbiota appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03785860 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03785860 about?

NCT03785860 is a clinical study titled "The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects". The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, ove...

What is the current status of trial NCT03785860?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-13. Estimated completion is 2019-12-23.

What conditions does trial NCT03785860 study?

This clinical trial studies the following conditions: Gut -Microbiota.

What interventions are being tested in trial NCT03785860?

The interventions under investigation include: Placebo (OTHER), Dietary Fiber (OTHER).

Who is sponsoring clinical trial NCT03785860?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03785860 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gut -Microbiota

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.